Chemical tracer diffusion of Sr and Co in polycrystalline Ca-deficient CaMnO3-δ with CaMn2O4 precipitates.
Diffusivity in the A- and B-sites CaMnO3 polycrystalline perovskite-δ-deficient Ca and spinel CaMn2O4 (marokite) as a secondary phase was studied using chemical tracers and secondary ion mass spectrometry (SIMS) equipped with electron probe microanalysis (EPMA). a thin film containing a chemical tracer Sr and Co is deposited on the polished surface of the polycrystalline composite samples followed by annealing at 800-1200 ° C for 96 hours. diffusion profile for each tracker is determined by SIMS, followed by calculation of the diffusion coefficient by fitting to the appropriate model.
Trackers Sr showed diffusion especially grating, with the activation energy of 210 ± 30 kJ mol-1, while the Co tracker shows the combination of lattice and enhanced grain boundary diffusion, with an activation energy of 270 ± 30 kJ mol-1 and 380 ± 40 kJ mol-1, each
The diffusivity can be used to predict the lifetime of the interdiffusion and the junctions between the n-type or CaMnO3 CaMnO3-δ-δ / CaMn2O4 composite and interlayers metallization or p-type material in the leg oxide thermoelectrics. In particular, relatively high diffusivity in polycrystalline CaMnO3 effective co-δ may play a role in reporting the rapid formation of a secondary phase (Ca3Co2-yMnyO6) between Ca3Co3.92O9 + p-type and n-type δ-δ CaMnO3 in a direct pn junction thermoelectric ,
A quick search in the database of scientific publications have demonstrated how the use of CRISPR-Cas genome engineering has considerably expanded edition, and growing importance, in modern molecular biology. Only in pub-med Platform, the search term gives more than 3000 results.
In particular, in Drug Discovery, Medicinal Chemistry and Chemical Biology in general CRISPR method may have multiple applications. Some of these applications are: resistance-election study of organic compounds lead antimalarial; druggability investigation; the development of animal models to test chemical compounds, etc. In this paper, we offer a review of the relevant scientific literature illustrated with specific examples of the application of CRISPR techniques for medicinal chemistry and chemical biology. We also present a general overview of the main trends regarding legal and ethical methods of genome editing.
active modulation of carbonate chemistry calcifying fluid (δ11B, B / Ca) and seasonal invariant coral calcification in the sub-tropical boundary.
Coral calcification depends on both the supply of dissolved inorganic carbon (DIC) and the up-regulation of pH on calcifying fluid (cf). Using geochemical proxies (δ11B, B / Ca, Sr / Ca, Li / Mg), we show seasonal changes in pHcf and DICcf to Acropora yongei and Pocillopora damicornis grown in-situ on Rottnest Island (32 ° S) in Western Australia , Changes in pHcf span of 8:38 in the summer to 8.60 in the winter, while DICcf is 25 to 30% higher during the summer than the winter (× 1.5 × 2 to the sea). Thus, the two variables is up-regulated far above the values of seawater and seasonal out of phase with each other.
BACE1 |
|||
MBS8534951-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
BACE1 |
|||
MBS8534951-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
BACE1 |
|||
MBS8534951-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
BACE1 |
|||
MBS556383-005mg | MyBiosource | 0.05mg | EUR 500 |
BACE1 |
|||
MBS556383-5x005mg | MyBiosource | 5x0.05mg | EUR 2100 |
bACE1 siRNA |
|||
20-abx908826 | Abbexa |
|
|
bACE1 siRNA |
|||
20-abx908827 | Abbexa |
|
|
bACE1 siRNA |
|||
20-abx900582 | Abbexa |
|
|
BACE1 protein |
|||
E62B011 | EnoGene | 20ug | EUR 225 |
BACE1 protein |
|||
MBS8574980-002mg | MyBiosource | 0.02mg | EUR 305 |
BACE1 protein |
|||
MBS8574980-5x002mg | MyBiosource | 5x0.02mg | EUR 1220 |
BACE1 Antibody |
|||
6651-100 | Biovision | each | EUR 418.8 |
BACE1 Antibody |
|||
6651-30T | Biovision | each | EUR 175.2 |
BACE1 antibody |
|||
20R-BR014 | Fitzgerald | 50 ug | EUR 709 |
Description: Rabbit polyclonal BACE1 antibody |
BACE1 antibody |
|||
20R-BR015 | Fitzgerald | 50 ug | EUR 709 |
Description: Rabbit polyclonal BACE1 antibody |
BACE1 Antibody |
|||
35650 | SAB | 100ul | EUR 319 |
BACE1 Antibody |
|||
35650-100ul | SAB | 100ul | EUR 302.4 |
BACE1 Antibody |
|||
E035650 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
BACE1 Antibody |
|||
E10-30625 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
BACE1 Antibody |
|||
E10-30625T | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
BACE1 Antibody |
|||
E19-7939-1 | EnoGene | 50ug/50ul | EUR 145 |
Description: Available in various conjugation types. |
BACE1 Antibody |
|||
E19-7939-2 | EnoGene | 100ug/100ul | EUR 225 |
Description: Available in various conjugation types. |
BACE1 Antibody |
|||
DF7939 | Affbiotech | 200ul | EUR 420 |
BACE1 Antibody |
|||
DF7939-100ul | Affinity Biosciences | 100ul | EUR 280 |
BACE1 Antibody |
|||
DF7939-200ul | Affinity Biosciences | 200ul | EUR 350 |
BACE1 antibody |
|||
E39-10412 | EnoGene | 100ug/100ul | EUR 225 |
Description: Available in various conjugation types. |
BACE1 Antibody |
|||
E305133 | EnoGene | 100ug/200ul | EUR 275 |
Description: Available in various conjugation types. |
BACE1 Antibody |
|||
E307287 | EnoGene | 100ug/200ul | EUR 275 |
Description: Available in various conjugation types. |
BACE1 antibody |
|||
70R-15953 | Fitzgerald | 50 ul | EUR 289 |
Description: Rabbit polyclonal BACE1 antibody |
BACE1 antibody |
|||
70R-7276 | Fitzgerald | 50 ug | EUR 467 |
Description: Rabbit polyclonal BACE1 antibody raised against the N terminal of BACE1 |
Bace1 antibody |
|||
70R-8662 | Fitzgerald | 50 ug | EUR 467 |
Description: Affinity purified rabbit polyclonal Bace1 antibody |
BACE1 Antibody |
|||
AF6650 | Affbiotech | 100ul | EUR 420 |
BACE1 Antibody |
|||
AF6650-100ul | Affinity Biosciences | 100ul | EUR 280 |
BACE1 Antibody |
|||
AF6650-200ul | Affinity Biosciences | 200ul | EUR 350 |
BACE1 Antibody |
|||
1-CSB-PA008418 | Cusabio |
|
|
Description: A polyclonal antibody against BACE1. Recognizes BACE1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, IF, ELISA;IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/5000 |
BACE1 Antibody |
|||
1-CSB-PA150463 | Cusabio |
|
|
Description: A polyclonal antibody against BACE1. Recognizes BACE1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000 |
BACE1 Antibody |
|||
1-CSB-PA173556 | Cusabio |
|
|
Description: A polyclonal antibody against BACE1. Recognizes BACE1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:15-1:50 |
BACE1 Antibody |
|||
1-CSB-PA002524GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against BACE1. Recognizes BACE1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
BACE1 Antibody |
|||
1-CSB-PA002524LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against BACE1. Recognizes BACE1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
BACE1 Antibody |
|||
ABD7939 | Nova Lifetech | 100ug | EUR 325 |
BACE1 Antibody |
|||
ABD7999 | Nova Lifetech | 100ug | EUR 325 |
BACE1 Antibody |
|||
F50757-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: Cerebral deposition of amyloid beta peptide is an early and critical feature of Alzheimer's disease. Amyloid beta peptide is generated by proteolytic cleavage of amyloid precursor protein (APP) by two proteases, one of which is BACE. This protein, a member of the peptidase A1 protein family, is a type I integral membrane glycoprotein and aspartic protease that is found mainly in the Golgi. |
BACE1 Antibody |
|||
F50758-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase. [UniProt] |
BACE1 Antibody |
|||
F50758-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
Description: Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase. [UniProt] |
Bace1 Antibody |
|||
GWB-MQ588C | GenWay Biotech | 50ug | Ask for price |
BACE1 Antibody |
|||
GWB-MQ589D | GenWay Biotech | 50ug | Ask for price |
BACE1 Antibody |
|||
MBS7136510-005mL | MyBiosource | 0.05mL | EUR 220 |
BACE1 Antibody |
|||
MBS7136510-01mL | MyBiosource | 0.1mL | EUR 300 |
BACE1 Antibody |
|||
MBS7136510-5x01mL | MyBiosource | 5x0.1mL | EUR 1350 |
BACE1 Antibody |
|||
MBS7123393-005mL | MyBiosource | 0.05mL | EUR 190 |
BACE1 Antibody |
|||
MBS7123393-01mL | MyBiosource | 0.1mL | EUR 270 |
BACE1 Antibody |
|||
MBS7123393-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
BACE1 Antibody |
|||
MBS7123394-005mL | MyBiosource | 0.05mL | EUR 190 |
BACE1 Antibody |
|||
MBS7123394-01mL | MyBiosource | 0.1mL | EUR 270 |
BACE1 Antibody |
|||
MBS7123394-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
BACE1 Antibody |
|||
MBS7047737-005mg | MyBiosource | 0.05mg | EUR 190 |
BACE1 Antibody |
|||
MBS7047737-01mg | MyBiosource | 0.1mg | EUR 270 |
BACE1 Antibody |
|||
MBS7047737-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
BACE1 Antibody |
|||
MBS7119262-005mg | MyBiosource | 0.05mg | EUR 150 |
BACE1 Antibody |
|||
MBS7119262-01mg | MyBiosource | 0.1mg | EUR 190 |
BACE1 Antibody |
|||
MBS7119262-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
BACE1 Antibody |
|||
MBS9407605-01mL | MyBiosource | 0.1mL | EUR 305 |
BACE1 Antibody |
|||
MBS9407605-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
BACE1 Antibody |
|||
MBS854853-01mg | MyBiosource | 0.1mg | EUR 345 |
BACE1 Antibody |
|||
MBS854853-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
BACE1 Antibody |
|||
MBS854853-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
BACE1 Antibody |
|||
MBS854853-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
BACE1 Antibody |
|||
MBS854853-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
BACE1 Antibody |
|||
MBS8517256-005mg | MyBiosource | 0.05mg | EUR 235 |
BACE1 Antibody |
|||
MBS8517256-01mg | MyBiosource | 0.1mg | EUR 305 |
BACE1 Antibody |
|||
MBS8517256-01mLAF405M | MyBiosource | 0.1mL(AF405M) | EUR 465 |
BACE1 Antibody |
|||
MBS8517256-01mLAF546 | MyBiosource | 0.1mL(AF546) | EUR 465 |
BACE1 Antibody |
|||
MBS8517256-01mLAF750 | MyBiosource | 0.1mL(AF750) | EUR 465 |
BACE1 Antibody |
|||
MBS8527259-01mg | MyBiosource | 0.1mg | EUR 345 |
BACE1 Antibody |
|||
MBS8527259-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
BACE1 Antibody |
|||
MBS8527259-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
BACE1 Antibody |
|||
MBS8527259-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
BACE1 Antibody |
|||
MBS8527259-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
BACE1 antibody |
|||
MBS535525-005mg | MyBiosource | 0.05mg | EUR 1125 |
BACE1 antibody |
|||
MBS535525-5x005mg | MyBiosource | 5x0.05mg | EUR 4905 |
BACE1 antibody |
|||
MBS535570-005mg | MyBiosource | 0.05mg | EUR 1125 |
BACE1 antibody |
|||
MBS535570-5x005mg | MyBiosource | 5x0.05mg | EUR 4905 |
BACE1 Antibody |
|||
MBS9608457-01mL | MyBiosource | 0.1mL | EUR 260 |
BACE1 Antibody |
|||
MBS9608457-02mL | MyBiosource | 0.2mL | EUR 305 |
BACE1 Antibody |
|||
MBS9608457-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
BACE1 Antibody |
|||
MBS9613671-01mL | MyBiosource | 0.1mL | EUR 260 |
BACE1 Antibody |
|||
MBS9613671-02mL | MyBiosource | 0.2mL | EUR 305 |
BACE1 Antibody |
|||
MBS9613671-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
BACE1-IN-6 |
|||
T39484-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: BACE1-IN-6 |
BACE1-IN-6 |
|||
T39484-1g | TargetMol Chemicals | 1g | Ask for price |
Description: BACE1-IN-6 |
BACE1-IN-6 |
|||
T39484-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: BACE1-IN-6 |
BACE1-IN-6 |
|||
T39484-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: BACE1-IN-6 |
BACE1-IN-6 |
|||
T39484-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: BACE1-IN-6 |
BACE1-IN-1 |
|||
HY-100182 | MedChemExpress | 5mg | EUR 2958 |
BACE1-IN-1 |
|||
T10450-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: BACE1-IN-1 |
BACE1-IN-1 |
|||
T10450-1g | TargetMol Chemicals | 1g | Ask for price |
Description: BACE1-IN-1 |
BACE1-IN-1 |
|||
T10450-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: BACE1-IN-1 |
BACE1-IN-1 |
|||
T10450-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: BACE1-IN-1 |
BACE1-IN-1 |
|||
T10450-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: BACE1-IN-1 |
BACE1-IN-2 |
|||
T10451-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: BACE1-IN-2 |
BACE1-IN-2 |
|||
T10451-1g | TargetMol Chemicals | 1g | Ask for price |
Description: BACE1-IN-2 |
BACE1-IN-2 |
|||
T10451-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: BACE1-IN-2 |
BACE1-IN-2 |
|||
T10451-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: BACE1-IN-2 |
BACE1-IN-2 |
|||
T10451-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: BACE1-IN-2 |
BACE1-IN-4 |
|||
T10452-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: BACE1-IN-4 |
BACE1-IN-4 |
|||
T10452-1g | TargetMol Chemicals | 1g | Ask for price |
Description: BACE1-IN-4 |
BACE1-IN-4 |
|||
T10452-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: BACE1-IN-4 |
BACE1-IN-4 |
|||
T10452-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: BACE1-IN-4 |
BACE1-IN-4 |
|||
T10452-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: BACE1-IN-4 |
BACE1-IN-5 |
|||
T10453-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: BACE1-IN-5 |
BACE1-IN-5 |
|||
T10453-1g | TargetMol Chemicals | 1g | Ask for price |
Description: BACE1-IN-5 |
BACE1-IN-5 |
|||
T10453-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: BACE1-IN-5 |
BACE1-IN-5 |
|||
T10453-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: BACE1-IN-5 |
BACE1-IN-5 |
|||
T10453-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: BACE1-IN-5 |
BACE1-IN-8 |
|||
T64074-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: BACE1-IN-8 |
BACE1-IN-8 |
|||
T64074-1g | TargetMol Chemicals | 1g | Ask for price |
Description: BACE1-IN-8 |
BACE1-IN-8 |
|||
T64074-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: BACE1-IN-8 |
BACE1-IN-8 |
|||
T64074-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: BACE1-IN-8 |
BACE1-IN-8 |
|||
T64074-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: BACE1-IN-8 |
BACE1-IN-6 |
|||
MBS5799951-5mg | MyBiosource | 5(mg | EUR 915 |
BACE1-IN-6 |
|||
MBS5799951-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
BACE1-IN-1 |
|||
MBS387057-10mg | MyBiosource | 10mg | EUR 4020 |
BACE1-IN-1 |
|||
MBS387057-1mg | MyBiosource | 1mg | EUR 840 |
BACE1-IN-1 |
|||
MBS387057-5mg | MyBiosource | 5mg | EUR 2400 |
BACE1-IN-1 |
|||
MBS387057-5x10mg | MyBiosource | 5x10mg | EUR 18090 |
BACE1-IN-4 |
|||
MBS3842926-10mg | MyBiosource | 10mg | EUR 810 |
BACE1-IN-4 |
|||
MBS3842926-5mg | MyBiosource | 5mg | EUR 465 |
BACE1-IN-4 |
|||
MBS3842926-5x10mg | MyBiosource | 5x10mg | EUR 3630 |
BACE1-IN-2 |
|||
MBS3843651-10mg | MyBiosource | 10mg | EUR 1905 |
BACE1-IN-2 |
|||
MBS3843651-1mg | MyBiosource | 1mg | EUR 430 |
BACE1-IN-2 |
|||
MBS3843651-5mg | MyBiosource | 5mg | EUR 1165 |
BACE1-IN-2 |
|||
MBS3843651-5x10mg | MyBiosource | 5x10mg | EUR 8565 |
BACE1-IN-1 |
|||
MBS5766121-5mg | MyBiosource | 5mg | EUR 915 |
BACE1-IN-1 |
|||
MBS5766121-5x5mg | MyBiosource | 5x5mg | EUR 3970 |
BACE1-IN-2 |
|||
MBS5766122-5mg | MyBiosource | 5mg | EUR 915 |
BACE1-IN-2 |
|||
MBS5766122-5x5mg | MyBiosource | 5x5mg | EUR 3970 |
BACE1-IN-4 |
|||
MBS5766123-5mg | MyBiosource | 5mg | EUR 915 |
BACE1-IN-4 |
|||
MBS5766123-5x5mg | MyBiosource | 5x5mg | EUR 3970 |
BACE1-IN-2 |
|||
HY-112444 | MedChemExpress | Get quote | Ask for price |
Description: BACE1-IN-2 is a 1,4-Oxazine β-Secretase 1 (BACE1) inhibitor with an IC50 of 22 nM[1]. |
BACE1-IN-5 |
|||
HY-130244 | MedChemExpress | Get quote | Ask for price |
Description: BACE1-IN-5 (Compound 15) is a β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor with an IC50 of 9.1 nM, and also inhibits cellular amyloid-β (Aβ) with an IC50 of 0.82 nM. BACE1-IN-5 has a medicinal chemistry that improves hERG inhibition and P-gp efflux[1]. |
BACE1-IN-8 |
|||
HY-144739 | MedChemExpress | Get quote | Ask for price |
Description: BACE1-IN-8 (compound 70b) is a potent BACE1 (β-site APP cleaving enzyme 1) inhibitor, with an IC50 of 3.9 µM[1]. |
BACE1-IN-9 |
|||
HY-144741 | MedChemExpress | Get quote | Ask for price |
Description: BACE1-IN-9 (compound 82b) is a potent BACE1 (β-site APP cleaving enzyme 1) inhibitor, with an IC50 of 1.2 µM[1]. |
BACE1-IN-4 |
|||
HY-128594 | MedChemExpress | Get quote | Ask for price |
Description: BACE1-IN-4 is a potent and highly selective BACE1 inhibitor, with an IC50 of 3.8 nM and a Ki of 1.9 nM, more selective at BACE1 over BACE2. Anti-Alzheimer’s disease[1]. |
BACE1-IN-6 |
|||
HY-145345 | MedChemExpress | Get quote | Ask for price |
Description: BACE1-IN-6 is a BACE1 inhibitor with an IC50 value of 1.5 nM. |
BACE1 Mouse mAb |
|||
E2220934 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
BACE1 Mouse mAb |
|||
E2221115 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
BACE1 Assay Kit |
|||
71656 | BPS Bioscience | 96 rxns. | EUR 530 |
Description: Bace1 (β-secretase 1) is an aspartic protease that is involved in the processing of the Amyloid precursor protein (APP). Cleavage of APP by BACE1 followed by γ-secretase results in β-amyloid peptide production, which ultimately leads toxic Aβ accumulation. In Alzheimer's disease (AD), it has been widely accepted that Aβ aggregation plays a critical role in AD pathogenesis, suggesting that BACE1 could be a potential target to treat AD. The BACE1 FRET Assay Kit is designed to measure BACE1 activity for screening and profiling applications based on fluorescence resonance energy transfer (FRET) using a labeled peptide substrate (below). |
BACE1-IN-12 |
|||
T63867-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: BACE1-IN-12 |
BACE1-IN-12 |
|||
T63867-1g | TargetMol Chemicals | 1g | Ask for price |
Description: BACE1-IN-12 |
BACE1-IN-12 |
|||
T63867-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: BACE1-IN-12 |
BACE1-IN-12 |
|||
T63867-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: BACE1-IN-12 |
BACE1-IN-12 |
|||
T63867-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: BACE1-IN-12 |
BACE1 siRNA (Rat) |
|||
MBS8238820-15nmol | MyBiosource | 15nmol | EUR 405 |
BACE1 siRNA (Rat) |
|||
MBS8238820-30nmol | MyBiosource | 30nmol | EUR 565 |
BACE1 siRNA (Rat) |
|||
MBS8238820-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
BACE1 Mouse mAb |
|||
MBS8539320-01mL | MyBiosource | 0.1mL | EUR 305 |
BACE1 Mouse mAb |
|||
MBS8539320-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
BACE1 Mouse mAb |
|||
MBS8539320-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
BACE1 Mouse mAb |
|||
MBS8539320-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
BACE1 Mouse mAb |
|||
MBS8539320-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
BACE1 Mouse mAb |
|||
MBS8539141-01mL | MyBiosource | 0.1mL | EUR 305 |
BACE1 Mouse mAb |
|||
MBS8539141-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
BACE1 Mouse mAb |
|||
MBS8539141-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
BACE1 Mouse mAb |
|||
MBS8539141-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
The net effect of these counter-cyclical behavior between DICcf and pHcf is that the aragonite saturation state of liquid whitewash (Ωcf) rose ~ 4 times over the values of seawater and ~ 25 to 40% higher during the winter than the summer , Thus, this coral control the chemical composition of the liquid whitewash to help maintain the level of calcification throughout the year in near-constant, despite the seasonal sea water temperature of only ~ 19 ° to 24 ° C. The ability of coral to up-regulate Ωcf is a key mechanism to optimize biomineralization, and thus it is important for the future of coral calcification under high CO2 conditions.